Trial Profile
Associations of fluorine-18 AV 1451 tau-positron emission tomography with age, ApoE genotype, and cognition in Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 21 Oct 2015 New trial record